These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32582190)

  • 1. Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins.
    Ghelani A; Bates D; Conner K; Wu MZ; Lu J; Hu YL; Li CM; Chaudhry A; Sohn SJ
    Front Immunol; 2020; 11():1106. PubMed ID: 32582190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice.
    Khoryati L; Pham MN; Sherve M; Kumari S; Cook K; Pearson J; Bogdani M; Campbell DJ; Gavin MA
    Sci Immunol; 2020 Aug; 5(50):. PubMed ID: 32817295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
    Peraino JS; Zhang H; Rajasekera PV; Wei M; Madsen JC; Sachs DH; Huang CA; Wang Z
    J Immunol Methods; 2014 Mar; 405():57-66. PubMed ID: 24462799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.
    Cheng G; Yu A; Malek TR
    Immunol Rev; 2011 May; 241(1):63-76. PubMed ID: 21488890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
    Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
    Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.
    Permanyer M; Bošnjak B; Glage S; Friedrichsen M; Floess S; Huehn J; Patzer GE; Odak I; Eckert N; Zargari R; Ospina-Quintero L; Georgiev H; Förster R
    Cell Mol Immunol; 2021 Feb; 18(2):398-414. PubMed ID: 33408345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response
    Ma S; So M; Ghelani A; Srivas R; Sahoo A; Hall R; Liu W; Wu H; Yu S; Lu S; Song E; Cariaga T; Soto M; Zhou H; Li CM; Chaudhry A; Luo X; Sohn SJ
    Front Immunol; 2023; 14():1257652. PubMed ID: 37809101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells.
    Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR
    Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
    Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
    Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo maintenance of human regulatory T cells during CD25 blockade.
    Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
    J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
    Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How GRAIL controls Treg function to maintain self-tolerance.
    Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
    Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
    Ding Y; Yu A; Tsokos GC; Malek TR
    J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species.
    Karakus U; Sahin D; Mittl PRE; Mooij P; Koopman G; Boyman O
    Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.
    Shi H; Liu C; Tan H; Li Y; Nguyen TM; Dhungana Y; Guy C; Vogel P; Neale G; Rankin S; Feng Y; Peng J; Tao W; Chi H
    Immunity; 2018 Nov; 49(5):899-914.e6. PubMed ID: 30413360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
    Bell CJ; Sun Y; Nowak UM; Clark J; Howlett S; Pekalski ML; Yang X; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Umana P; Klein C; Hosse RJ; Wicker LS; Peterson LB
    J Autoimmun; 2015 Jan; 56():66-80. PubMed ID: 25457307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
    Yu A; Malek TR
    J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.